Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
PLSE

PLSE - Pulse Biosciences Inc Stock Price, Fair Value and News

$21.60+0.30 (+1.41%)
Delayed

12/100

PLSE

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

12/100

PLSE

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

PLSE Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PLSE Price Action

Last 7 days

19.1%

Last 30 days

-14.5%

Last 90 days

51.7%

Trailing 12 Months

27.1%

PLSE RSI Chart

PLSE Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PLSE Valuation

Market Cap

1.5B

Price/Earnings (Trailing)

-20.18

Price/Sales (Trailing)

4.2K

EV/EBITDA

18.96

Price/Free Cashflow

-26.98

PLSE Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

PLSE Fundamentals

PLSE Revenue

Revenue (TTM)

350.0K

Rev. Growth (Yr)

667.44%

Rev. Growth (Qtr)

206.98%

PLSE Earnings

Earnings (TTM)

-72.8M

Earnings Growth (Yr)

10.07%

Earnings Growth (Qtr)

10.07%

PLSE Profitability

Operating Margin

-54.00%

EBT Margin

20800.00%

Return on Equity

-90.24%

Return on Assets

-76.99%

Free Cashflow Yield

-3.71%

PLSE Investor Care

Shares Dilution (1Y)

3.13%

PLSE Alerts

  • 1 major insider sales recently.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025560.0K490.0K420.0K350.0K
2024000630.0K
20221.9M2.1M1.6M700.0K
202100682.0K1.4M
20200607.0K326.0K0
20190000
Get all data in R, Python etc through our Historical Stock Data APIs

About Pulse Biosciences Inc

PLSE
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward, California.
 WEBSITEpulsebiosciences.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES61

Pulse Biosciences Inc Frequently Asked Questions

PLSE is the stock ticker symbol of Pulse Biosciences Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of Pulse Biosciences Inc is 1.47 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Mar 13 2026, PLSE's PE ratio (Price to Earnings) is -20.18 and Price to Sales (PS) ratio is 4.2 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PLSE PE ratio will change depending on the future growth rate expectations of investors.